The Companies and Markets show: Centrica, luxury goods, SJP and GSK
Investors' Chronicle
00:00
GSK's Future Growth Prospects
GSK is facing a massive lawsuits in the US on various different levels of allegations about side effects from Zantec. In terms of its future, though, as well as the shingles vaccine, the HIV set of treatments, there's been some progress there as well. Is that really where investors should be looking when they're looking at future growth prospects for GSK? I think at least in the short term, it clearly is. But again, be wary of the fact that this is concentrated in one disease area.
Transcript
Play full episode
